Search Results - "Ravish, H S"

Safety and Immunogenicity of a novel three-dose recombinant nanoparticle rabies G protein vaccine administered as simulated post exposure immunization: A randomized, comparator controlled, multicenter, phase III clinical study by H S, Ravish, Khobragade, Akash, Satapathy, Durga, Gupta, Monica, Kumar, Surendra, Bhomia, Vinay, V, Ramasubramanian, Desai, Maharshi, Agrawal, Ashok Dilipkumar

“…Rabies vaccines are lifesaving in human post animal exposure. However, the compliance to the complete course of vaccine is found to be only 60%. Hence, there…”
Get full text

IJCM_280A: A prospective study on safety and clinical efficacy of rabies biologicals in paediatric patients with category III animal exposure by Fotedar, Nidhi, Ravish, HS

“…Background: Rabies remains a significant public health concern worldwide, particularly among paediatric populations who are vulnerable to animal exposures…”
Get full text

A prospective study on health seeking behaviour and post exposure prophylaxis received by animal bite victims at the anti-rabies clinic in a tertiary care centre of urban Bangalore [version 1; peer review: awaiting peer review] by Surendran, Jithin, HS, Ravish, Kumari, Nitu, M Prasanth, Ramya, Fotedar, Nidhi

“…Background Rabies is 100% preventable by administering early and complete post exposure prophylaxis (PEP). Animal bite victims must have the knowledge and…”
Get full text

Comparison of a Novel Human Rabies Monoclonal Antibody to Human Rabies Immunoglobulin for Postexposure Prophylaxis: A Phase 2/3, Randomized, Single-Blind, Noninferiority, Controlled Study by Gogtay, Nithya J, Munshi, Renuka, Ashwath Narayana, D H, Mahendra, B J, Kshirsagar, Vikas, Gunale, Bhagwat, Moore, Susan, Cheslock, Peter, Thaker, Saket, Deshpande, Siddharth, Karande, Sunil, Kumbhar, Dipti, Ravish, H S, Harish, B R, Pisal, Sambhaji S, Dhere, Rajeev, Parulekar, Varsha, Blackwelder, William C, Molrine, Deborah C, Kulkarni, Prasad S

“…Lack of access to rabies immunoglobulin (RIG) contributes to high rabies mortality. A recombinant human monoclonal antibody (SII RMAb) was tested in a…”
Get full text

IJCM_365A: A prospective study on the safety and clinical efficacy of rabies monoclonal antibodies for post exposure prophylaxis in suspected animal exposures at the anti rabies clinic of KIMS Hospital and Research Centre, Bangalore by Poornima, M K, Ravish, H S, Sowmyashree, U

“…Background: Rabies immunoglobulins will provide timely passive immunity after exposure to suspected rabid animals along with thorough wound wash and full…”
Get full text

Comparative study on the immunogenicity and safety of a purified chick embryo cell rabies vaccine (PCECV) administered according to two different simulated post exposure intramuscular regimens (Zagreb versus Essen) by Mahendra, BJ, Narayana, DH Ashwath, Agarkhedkar, Sharad, Ravish, HS, Harish, BR, Agarkhedkar, Shalaka, Madhusudana, SN, Belludi, Ashwin, Ahmed, Khaleel, Jonnalagedda, Rekha, Vakil, Hoshang, Bhusal, Chiranjiwi, Arora, Ashwani Kumar

“…Despite availability of effective rabies vaccines, India has the highest global mortality rate for rabies. Low socio-economic communities are most affected due…”
Get full text

Safety and immunogenicity of a quadrivalent meningococcal conjugate vaccine (MenACYW-DT): A multicenter, open-label, non-randomized, phase III clinical trial by Yadav, Sangeeta, Manglani, M. V., Ashwath Narayan, D. H., Sharma, S., Ravish, H. S., Arora, Rohit, Bosch Castells, V., Arya, S., Oster, P.

“…Objective To assess the safety and immunogenicity of a quadrivalent meningococcal (groups A,C,Y,W) polysaccharide diphtheria toxoid conjugate vaccine…”
Get full text

Is the skin sensitivity test required for administering equine rabies immunoglobulin? by Sudarshan, M K, Ashwath Narayana, D H, Ravish, H S

“…Rabies immunoglobulins are life-saving in patients with severe exposure to rabies. Despite the high degree of purification of equine rabies immunoglobulin…”
Get full text

Coverage evaluation of mass drug administration for lymphatic filariasis in Bidar district, Karnataka, India by Ravish, H, Undi, Malatesh, Rachana, A

“…Background: Lymphatic filariasis is one of the oldest and most debilitating of all the neglected tropical diseases. To interrupt transmission of this disease…”
Get full text

Assessing the Safety of Post-exposure Rabies Immunization in Pregnancy by Sudarshan, Mysore Kalappa, Ananda Giri, M.S., Mahendra, Bangalore J., Venkatesh, G.M., Sanjay, Thitamaranahalli V., Ashwath Narayana, D.H., Ravish, H.S.

“…Fourteen pregnant women who received rabies post-exposure prophylaxis (PEP) at the anti-rabies clinic (ARC) of Kempegowda Institute of Medical Sciences (KIMS)…”
Get full text

Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine versus a quadrivalent meningococcal conjugate vaccine in adults in India: an observer-blind, randomised, active-controlled, phase 2/3 study by Kulkarni, Prasad S, Kawade, Anand, Kohli, Sunil, Munshi, Renuka, Maliye, Chetna, Gogtay, Nithya J, S, Ravish H, Singh, Kiranjit, Vengadakrishnan, K, Panigrahi, Sandeep Kumar, Sahoo, Jyotiranjan, Bavdekar, Ashish, Garg, B S, Raut, Abhishek, Raj, Jeffrey P, Saxena, Unnati, Chaudhari, Vijaya L, Patil, Rakesh, Venkatarao, Epari, Kumari, Nitu, Surendran, Jithin, Parulekar, Varsha, Gagnon, Luc, Gensale, Tania, Dharmadhikari, Abhijeet, Gairola, Sunil, Kale, Sameer, Pisal, Sambhaji S, Dhere, Rajeev M, Mallya, Asha, Poonawalla, Cyrus S, Kapse, Dhananjay

“…Meningococcal disease remains an important public health problem globally. We assessed the non-inferiority and the lot-to-lot consistency of a pentavalent…”
Get full text

Induced Abortions and Concurrent Adoption of Contraception by Rachana AR, Ravish HS, Parasuramalu BG

Get full text

Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study by Kulkarni, Prasad S., Kadam, Abhijit, Godbole, Sheela, Bhatt, Varsha, Raut, Abhishek, Kohli, Sunil, Tripathi, Santanu, Kulkarni, Praveen, Ludam, Rakhi, Prabhu, Madhav, Bavdekar, Ashish, Gogtay, Nithya J., Meshram, Sushant, Kadhiravan, Tamilarasu, Kar, Sonali, Narayana, D.H. Ashwath, Samuel, Clarence, Kulkarni, Govind, Gaidhane, Abhay, Sathyapalan, Dipu, Raut, Sidram, Hadda, Vijay, Bhalla, Hira Lal, Bhamare, Chetanraj, Dharmadhikari, Abhijeet, Plested, Joyce S., Cloney-Clarke, Shane, Zhu, Mingzhu, Pryor, Melinda, Hamilton, Stephanie, Thakar, Madhuri, Shete, Ashwini, Gautam, Manish, Gupta, Nivedita, Panda, Samiran, Shaligram, Umesh, Poonawalla, Cyrus S., Bhargava, Balram, Gunale, Bhagwat, Kapse, Dhananjay, Kanitkar, Shubhangi A., Kakrani, Arjun L., Tripathy, Srikanth P., Tilak, Abhijit V., Dhamne, Akshay A., Mirza, Shahzad Beg, Athavale, Prachi V., Bhowmik, Mandakini, Ratnakar, Parag J., Gupta, Subodh, Deotale, Vijayshri, Jain, Jyoti, Kalantri, Ashwini, Jain, Vineet, Goyal, Nidhi, Arya, Alok, Rongsen-Chandola, Temsunaro, Dasgupta, Shreyasi, Periera, Pratibha, A, Vanmathi, Kawade, Anand, Gondhali, Arunkumar, Kudyar, Palvi, Singh, Abhishek, Yadav, Ravi, Alexander, Alina, Gunasekaran, Venugopalan, Dineshbabu, Sekar, Samantaray, P.C., Ravish, H.S., Kamra, Deepshikha, Gaidhane, Shilpa, Zahiruddin, Quazi Syed, Moni, Merlin, Kumar, Anil, Dravid, Ameet, Mohan, Anant, Suri, Tejas, Patel, Tejas K., Kishore, Surekha, Choche, Rahul, Ghatage, Deepak, Salvi, Sugam

“…NVX-CoV2373, a Covid-19 vaccine was developed in the USA with ∼90% efficacy. The same vaccine is manufactured in India after technology transfer (called as…”
Get full text

Boosting effect of purified chick embryo cell rabies vaccine using the intradermal route in persons previously immunized by the intramuscular route or vice versa by Sudarshan, M K, Madhusudana, S N, Mahendra, B J, Narayana, D H Ashwath, Giri, M S Ananda, Muhamuda, K, Ravish, H S, Venkatesh, G M

“…At present, in the event of re-exposure to rabies, 2 booster doses are recommended for people who have been previously vaccinated with cell culture rabies…”
Get full text